These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38405890)
1. Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial. Schuster NM; Wallace MS; Marcotte TD; Buse DC; Lee E; Liu L; Sexton M medRxiv; 2024 Feb; ():. PubMed ID: 38405890 [TBL] [Abstract][Full Text] [Related]
2. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study. Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial. Lipton RB; Thiry A; Morris BA; Croop R J Pain Res; 2024; 17():2431-2441. PubMed ID: 39070853 [TBL] [Abstract][Full Text] [Related]
4. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial. Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890 [TBL] [Abstract][Full Text] [Related]
5. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569 [TBL] [Abstract][Full Text] [Related]
6. Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine. Doty EG; Krege JH; Jin L; Raskin J; Halker Singh RB; Kalidas K Cephalalgia; 2019 Oct; 39(12):1569-1576. PubMed ID: 31266353 [TBL] [Abstract][Full Text] [Related]
7. Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial. Dodick DW; Tepper SJ; Friedman DI; Gelfand AA; Kellerman DJ; Schmidt PC Headache; 2018 Jul; 58(7):986-992. PubMed ID: 29782049 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches. Tepper SJ; Dodick DW; Schmidt PC; Kellerman DJ Headache; 2019 Apr; 59(4):509-517. PubMed ID: 30698272 [TBL] [Abstract][Full Text] [Related]
10. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks. Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016 [TBL] [Abstract][Full Text] [Related]
11. Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial. Winner PK; McAllister P; Chakhava G; Ailani J; Ettrup A; Krog Josiassen M; Lindsten A; Mehta L; Cady R JAMA; 2021 Jun; 325(23):2348-2356. PubMed ID: 34128999 [TBL] [Abstract][Full Text] [Related]
12. Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials. Hindiyeh NA; Kellerman DJ; Schmidt PC Headache; 2019 May; 59(5):819-824. PubMed ID: 30953576 [TBL] [Abstract][Full Text] [Related]
13. Cannabis-based medicines and medical cannabis for adults with cancer pain. Häuser W; Welsch P; Radbruch L; Fisher E; Bell RF; Moore RA Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014915. PubMed ID: 37283486 [TBL] [Abstract][Full Text] [Related]
14. Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies. Ashina M; Vasudeva R; Jin L; Lombard L; Gray E; Doty EG; Yunes-Medina L; Kinchen KS; Tassorelli C Headache; 2019 Nov; 59(10):1788-1801. PubMed ID: 31529622 [TBL] [Abstract][Full Text] [Related]
15. A Double-Blind, Randomized, Controlled Crossover Trial of Cannabis in Adults with Tourette Syndrome. Abi-Jaoude E; Bhikram T; Parveen F; Levenbach J; Lafreniere-Roula M; Sandor P Cannabis Cannabinoid Res; 2023 Oct; 8(5):835-845. PubMed ID: 36040329 [No Abstract] [Full Text] [Related]
16. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. Langford RM; Mares J; Novotna A; Vachova M; Novakova I; Notcutt W; Ratcliffe S J Neurol; 2013 Apr; 260(4):984-97. PubMed ID: 23180178 [TBL] [Abstract][Full Text] [Related]